Definitive Healthcare (NASDAQ:DH) Updates FY 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share guidance of 0.340-0.350 for the period, compared to the consensus earnings per share estimate of 0.330. The company issued revenue guidance of $250.0 million-$251.0 million, compared to the consensus revenue estimate of $249.2 million. Definitive Healthcare also updated its Q4 guidance to $0.07 EPS.

Definitive Healthcare Price Performance

NASDAQ DH traded down $0.07 on Friday, hitting $4.24. 1,200,343 shares of the company’s stock were exchanged, compared to its average volume of 326,752. The stock has a 50-day moving average of $4.36 and a 200-day moving average of $4.98. The company has a current ratio of 2.40, a quick ratio of 2.40 and a debt-to-equity ratio of 0.27. Definitive Healthcare has a 52 week low of $3.19 and a 52 week high of $10.62. The stock has a market cap of $500.02 million, a price-to-earnings ratio of -1.22, a P/E/G ratio of 6.27 and a beta of 1.33.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on DH shares. Robert W. Baird lowered their price target on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a report on Friday. Morgan Stanley lowered their price target on shares of Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a report on Tuesday, August 6th. JPMorgan Chase & Co. downgraded shares of Definitive Healthcare from a “neutral” rating to an “underweight” rating and lowered their price target for the stock from $7.00 to $5.00 in a report on Wednesday, July 31st. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a report on Friday, August 9th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $5.81.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.